HDL Therapeutics's Chairman of the Board, CEO is Michael M. Matin. HDL Therapeutics's key executives include Michael M. Matin and 5 others.


Key Executive Tracking

Receive notifications of key executive changes

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu